Introduction
Bioactive calcium phosphate ceramics have been widely used for bone regeneration. However, depending on the clinical application, these materials need to exhibit varying degrees of biodegradability. For example, in clinical applications in which implants are to be inserted into the regenerated site, rapid biodegradability is more important compared to applications in which this is not the case. Therefore, there have been numerous efforts to develop novel materials with a higher solubility compared to tricalcium phosphate (TCP). Among the various calcium phosphate materials which are currently clinically available, TCP possesses the highest solubility and biodegradability. The most reliable method for evaluating a bone substitute material's capability to degrade and promote bone formation and osseous regeneration is by performing histomorphometric measurements on ex vivo specimens from animal experiments. Animal studies, however, are very cost-intensive. Furthermore, due to an increasing focus on animal ethics, there has been an ongoing search for alternative in vitro methods which can contribute to reducing the number of animal experiments.
Consequently, this study compares an in vitro method for evaluating the biodegradability of novel calcium-alkali-orthophosphate ceramic particulates -by using solubility measurements -to histomorphometric evaluation of the biodegradability of these materials by determining the decrease of particle size in histological sections which were obtained subsequent to implantation in vivo using a sheep model.
Material and Methods
Three novel calcium-alkali-orthophosphate ceramic bone substitute materials were studied. These materials are glassy-crystalline materials with a higher solubility than β-tricalcium phosphate [1] [2] [3] . The composition of these materials is rather similar, since their main crystalline phase is the new phase Ca 2 KNa(PO 4 ) 2 [4] . In addition to the crystalline phase Ca 2 KNa(PO 4 ) 2 these three bone substitute materials contain small amorphous portions with differing quality and quantity. These amorphous portions result from small additions of MgO (material denominated GB14), MgO and SiO 2 (material denominated GB9) or both components as well as P 2 O 5 (material denominated GB9/25). GB9/25 [3] also contains a small portion of crystalline and amorphous diphosphates (Ca 2 P 2 O 7 ), unlike GB9, which does not [1] [2] . GB14, GB9 and GB9/25 particulates were made using reagent grade CaHPO 4 , Na 2 CO 3 , K 2 CO 3 , MgCO 3 , SiO 2 and H 3 PO 4 . These compounds were mixed and a melt was formed in a platinum crucible at about 1550°C for 2 hours. The material was cast, crushed and sieved to produce granules with a narrow range grain size of 355-400µm.
The solubility of the GB14, GB9 and GB9/25 particulates was determined by immersion in TRIS buffer solution 0.1M (pH7.4, 37°C) according DIN ISO EN10993-14. Immersion experiments of GB14, GB9 and GB9/25 particulates (grain size of 355-400µm) were performed for periods up to 15 weeks in order to extend the in vitro study over a time period which would be comparable to the implantation period in vivo. The concentration of the leached ions was determined at 5 and 7 days and then weekly by ICP-OES throughout the 15 week time period. This was in addition to determining the decrease of particle size weekly by light microscopy and morphometry.
Furthermore an in vivo study was performed, in which the same bone substitute materials (GB14, GB9 and GB9/25 particulates with a grain size of 355-400µm) were implanted in the sheep mandible to regenerate membrane protected critical size defects as described by von Arx et al. [5] . After 4, 12 and 24 weeks of implantation the mandibles were harvested and the augmented sites were processed for histological evaluation. This implied PMMA embedding and preparation of undecalcified sawed sections of the implanted bone substitute materials and the surrounding bone tissue. In order to characterize the biodegradation of these novel bone substitute materials quantitative evaluation of the decrease of particle size was performed by histomorphometry using a light microscope in combination with a digital camera (Colourview III) and SIS Analysis software (Olympus, Germany). This was in addition to measuring the amount of bone formed as well as the bone-particle contact. Furthermore, histological sections were stained for Tartrate Resistant Acid Phosphatase (TRAP) acticity in order to examine the presence and involvement of osteoclasts in the degradation process of the calcium-alkali-phosphate materials studied. In addition, synchroton-CT scans of the PMMA embedded tissue blocks were obtained prior to sectioning. The use of monochromatic synchrotron-radiation for microtomography generates images of high spatial resolution. Moreover, it facilitates visualizing the distribution of the newly formed bone and the residual particles in a three-dimensional manner.
Results and Discussion
The immersion experiments for determining the solubility of the various test materials in TRIS buffer solution 0.1M (pH7.4, 37°C) yielded the following results. According to DIN ISO EN10993-14 the solubility was first determined after 120h (5days). Figure 1 shows the amounts of ions which leached from GB9/25, GB9 and GB 14 throughout the first 5 days of immersion. Consequently, within the first 5 days considerable differences were noted with respect to ion-leaching when comparing GB9/25, GB9 and GB14 to each other. When extending the immersion experiments over periods of up to 15 weeks, a leaching of the majority of the alkali-ions was observed at two weeks with GB9 samples, whereas with GB14 this process occured after 4 weeks and with GB9/25 after 8 weeks [ Fig.2 ]. This phenomenon is probably caused by the differences in composition and quantity of the amorphous phase of the various materials. It is also noteworthy that the time point, at which the leaching of the alkali -ions occurs, can be influenced by varying the temperature or the concentration of the TRIS buffer solution. Moreover, these observations suggest that the biodegradation or resorption process of these calcium-alkali-orthophosphate materials is diffusion controlled. This is in contrast to the degradation process encountered with TCP particulates which exhibit a more uniform solubility. After complete leaching of the alkali-components had occurred from GB9/25, GB9 and GB14, hydroxyapatite formation was noted in the leached granules, whose composition had significantly changed compared to the native particulates [ Fig.3 ]. However, the grain size of the particulates did hardly change over the 15 week immersion period. This was in contrast to the in vivo findings, in which a considerable decrease of particle size was noted as well in Synchroton CT-Scan as in microscopic determination of the grain cut areas. The area of cut measured for GB9 particles was 0.132 mm 2 after 12 weeks and 0.032 mm 2 after 24 weeks of implantation.With GB9/25 particles, the area of cut determined at 12 weeks was 0.074 mm 2 and decreased to 0.055 mm 2 at 24 weeks. Furthermore, no multinucleate TRAP-positive osteoclasts were found in the osseous tissue surrounding or infiltrating the degrading GB9, GB9/25 and GB14 particles. These findings indicate that these materials resorb by dissolution rather than osteoclastic activity. Our observations are in agreement with those by Zerbo et al. [6] for TCP particulate that also reported a lack of of large multinucleate TRAP-positive cells and concluded that resorption of the TCP particles by osteoclasts plays only a minor role in its replacement by bone.
However, the morphological appearance of the residual granules observed after 12 weeks of implantation in the sheep mandible was similar to that of the leached particles which were obtained after 15 weeks of immersion in TRIS buffer solution, indicating that extensive leaching as well as dissolution and reprecipitation phenomena had occurred in the centre of the particles. The differences, which were observed with respect to particle size between the in vitro and in vivo setting, might be related to the presence of an array of proteins which are present in the in vivo settings. Immersion experiments, in which immersion of bioactive ceramics in protein-free solutions was compared to that in solutions which contained serum-proteins, demonstrated that the surface structure morphology of the surface reaction layer that forms due to dissolution and reprecipitation phenomena was significantly different when serum-proteins were present. Furthermore, the reaction kinetics were significantly influenced by the presence of serum proteins [7, 8] . Consequently, studies to elucidate the surface transformations of these novel bioactive calcium-alkali-orthophosphate ceramics and the protein adsorption events associated with immersion in biological fluids are currently underway [9, 10] .
